SCHEMBL19485698

SCHEMBL19485698

CC(=O)c1ccc(C[C@H](C)C(=O)O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.55
LMNA P02545 4/20 0.53
HSD17B10 Q99714 1/20 0.53
PPARG P37231 2/20 0.51
PPARA Q07869 2/20 0.51
TBXAS1 P24557 2/20 0.50
ACACB O00763 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
EPHX2 P34913 1/20 0.47
PTGS1 P23219 3/20 0.46
PTGS2 P35354 3/20 0.46
CYP2C9 P11712 2/20 0.46
AKR1C3 P42330 2/20 0.46
CXCR1 P25024 2/20 0.46
CXCR2 P25025 2/20 0.46
ALB P02768 1/20 0.46
ESR1 P03372 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12142803 1.00 KMT2A (0.55) KMT2ALMNAHSD17B10PPARGPPARA
SCHEMBL11237591 0.88 TBXAS1 (0.59) LMNATBXAS1HPGDPTGS1PTGS2
SCHEMBL11632648 0.86 KMT2A (0.57) KMT2ALMNAHSD17B10PPARGPPARA
SCHEMBL14640265 0.86 ALDH1A1 (0.55) KMT2ALMNAPPARGTBXAS1ACACB
SCHEMBL24294931 0.85 TBXAS1 (0.48) LMNAPPARGTBXAS1ACACBEPHX2
SCHEMBL13594789 0.85 TBXAS1 (0.51) LMNAPPARGTBXAS1ACACBEPHX2
SCHEMBL15905964 0.85 TBXAS1 (0.51) LMNAPPARGTBXAS1ACACBEPHX2
SCHEMBL24295254 0.84 TBXAS1 (0.47) LMNAPPARGPPARATBXAS1ACACB
SCHEMBL13594791 0.82 EPHX2 (0.46) KMT2ALMNAPPARGTBXAS1ACACB
SCHEMBL585471 0.82 LMNA (0.64) KMT2ALMNAHSD17B10ACACBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9797908-B2 Unnatural reactive amino acid genetic code additions THE SCRIPPS RESEARCH INSTITUTE (US) 2017-10-24 US disclosed